Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 9 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

6(85.7%)

Early Phase 1

1(14.3%)

7Total

N/A(6)

Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT06738420Not ApplicableCompleted

Medical Nutrition Formulations Enriched With Postbiotics for the Management of Gastrointestinal Disorders

Role: lead

NCT07027943Not ApplicableCompleted

Evaluation Of The Diamine Oxidase Supplementation Effect In Patients With Insomnia Symptoms

Role: lead

NCT07006558Not ApplicableCompleted

Kinetic Study Of Supplementation With The Enzyme Diamine Oxidase In Patients With Histamine Intolerance

Role: lead

NCT06715163Not ApplicableCompleted

Evaluation of the Safety and Tolerability of Three Doses of Diamine Oxidase (DAO) in Healthy Volunteers

Role: lead

NCT06488027Completed

DAO DEFICIENCY SCREENING AMONG PATIENTS WITH INSOMNIA SYMPTOMS

Role: lead

NCT06738433Early Phase 1Completed

Efficacy and Tolerability of ABB I5 Prebiotic and ABB C22 Postbiotics for the Management of Constipation and Gastrointestinal Well-being: a Pilot Trial

Role: lead

NCT06710366Completed

Prevalence of DAO (diamino Oxidase) Deficiency in Newborns

Role: lead

NCT05389761Not ApplicableCompleted

Fibromyalgia Treatment With Enzyme DAO

Role: collaborator

NCT04798677Not ApplicableCompleted

Efficacy and Tolerability of ABBC1 in Volunteers Receiving the Influenza or Covid-19 Vaccine

Role: lead

All 9 trials loaded